Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

American Home Products patents selective, orally active, nonpeptide V2 agonists

March 24, 1999

Piperazine derivatives for lower urinary tract disorders designed at Recordati

March 23, 1999

Ono-4057: BLT receptor antagonist with beneficial effects in rat model of nephritis

March 22, 1999

TGF-beta inhibitors for nephritis disclosed by Tsumura

March 16, 1999

Zeria patents new series for BPH

March 15, 1999

Orally active, selective V2 agonists in development at AHP

March 12, 1999

Recordati claims potent and selective 5-HT1A receptor antagonists for urinary disorders

March 12, 1999

New Drug Submission for Ditropan accepted for review in Canada

March 10, 1999

Microbially produced 5alpha-reductase inhibitor discovered at Snow Brand

March 9, 1999

Licensing opportunity from VUFB: alpha2-adrenoceptor antagonist for BPH and heart failure

Feb. 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...